Prognostic value of soluble factors of angiogenesis and adhesion processes in head and neck squamous cell carcinomas

被引:0
作者
Gun, Taylan [1 ]
Ikinciogullari, Aykut [2 ]
Boztepe, Osman Fatih [3 ]
Ensari, Serdar [4 ]
Dere, Huseyin [5 ]
机构
[1] Bahcesehir Univ, Fac Med, Ankara Med Pk Hosp, Ankara, Turkey
[2] Ankara Numune Training & Res Hosp, Ankara, Turkey
[3] ENT Specialist Antalya Med Pk Hosp, Antalya, Turkey
[4] Karabuk Univ, Fac Med, Karabuk, Turkey
[5] Yildirim Beyazit Univ, Fac Med, Ankara, Turkey
关键词
Vascular Cell Adhesion Molecule; Vascular Endothelial Growth Factor; Prognosis;
D O I
10.4328/JCAM.5788
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: In this study, we aimed to define the prognostic value of two factors related to angiogenesis and adhesion processes of head and neck squamous cell carcinomas. The prominent angiogenesis molecule is vascular endothelial growth factor (VEGF). The vascular cell adhesion molecule (VCAM) first attracted attention more than two decades ago as endothelial adhesion receptor with key function for leukocyte recruitment in term of cellular immune response. Material and Method: 35 patients with head and neck squamous cell carcinomas were enrolled in this study. The control group consisted of 20 people who had no sign of regional or systemic diseases. 33 patients were male and 2 patients were female. Mean age was 59.7 years (28-76). Results: We showed that VEGF levels in the patient group were significantly higher than in the control group (p=0.001). However, when comparing the VEGF levels of different stages, there was no statistical significant difference between the stages. Discussion: Serum VEGF levels can provide sufficient information for the early diagnosis of the disease but prognosis may not be evaluated according to the results of our study. VCAM levels were not specific and sensitive to use as a tumor marker but VCAM may be a valuable factor to determine the prognosis and tumor aggression in cancer patients.
引用
收藏
页码:421 / 424
页数:4
相关论文
共 22 条
  • [1] CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1), E-SELECTIN AND VASCULAR CELL-ADHESION MOLECULE-1 (VCAM-1) IN HUMAN MALIGNANCIES
    BANKS, RE
    GEARING, AJH
    HEMINGWAY, IK
    NORFOLK, DR
    PERREN, TJ
    SELBY, PJ
    [J]. BRITISH JOURNAL OF CANCER, 1993, 68 (01) : 122 - 124
  • [2] Expression of vascular endothelial growth factor in basal cell carcinoma and cutaneous squamous cell carcinoma of the head and neck
    Bowden, J
    Brennan, PA
    Umar, T
    Cronin, A
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2002, 29 (10) : 585 - 589
  • [3] Chen Z, 1999, CLIN CANCER RES, V5, P1369
  • [4] Prognostic significance of adhesion molecules (sICAM-1, sVCAM-1) and VEGF in colorectal cancer patients
    Dymicka-Piekarska, Violetta
    Guzinska-Ustymowicz, Katarzyna
    Kuklinski, Adam
    Kemona, Halina
    [J]. THROMBOSIS RESEARCH, 2012, 129 (04) : E47 - E50
  • [5] Eggeman H, 2011, ANTICANCER RES, V31, P2617
  • [6] Role of angiogenic factors: Coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma
    Eisma, RJ
    Spiro, JD
    Kreutzer, DL
    [J]. LARYNGOSCOPE, 1999, 109 (05) : 687 - 693
  • [7] Kato H, 2002, ANTICANCER RES, V22, P3977
  • [8] KUZU I, 1993, LAB INVEST, V69, P322
  • [9] Circulating intercellular adhesion molecule 1 (ICAM-1), E-selectin and vascular cell adhesion molecule 1 (VCAM-1) in head and neck cancer
    Liu, CM
    Sheen, TS
    Ko, JY
    Shun, CT
    [J]. BRITISH JOURNAL OF CANCER, 1999, 79 (02) : 360 - 362
  • [10] Lymphatic and Angiogenic Candidate Genes Predict the Development of Secondary Lymphedema following Breast Cancer Surgery
    Miaskowski, Christine
    Dodd, Marylin
    Paul, Steven M.
    West, Claudia
    Hamolsky, Deborah
    Abrams, Gary
    Cooper, Bruce A.
    Elboim, Charles
    Neuhaus, John
    Schmidt, Brian L.
    Smoot, Betty
    Aouizerat, Bradley E.
    [J]. PLOS ONE, 2013, 8 (04):